NCT06247527

Brief Summary

The proposed PROACT study will test the effectiveness of a mental health intervention (psychotherapy) for multiple common mental health conditions (depressive, anxiety and trauma symptoms) among adolescents and youth with HIV in Kenya. The study will also evaluate key factors for successful intervention implementation and conduct an economic evaluation to inform future intervention scale-up.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for not_applicable

Timeline
24mo left

Started May 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
May 2024May 2028

First Submitted

Initial submission to the registry

January 29, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 8, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
2.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2028

Expected
Last Updated

February 8, 2024

Status Verified

February 1, 2024

Enrollment Period

1.6 years

First QC Date

January 29, 2024

Last Update Submit

February 6, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Depressive symptoms

    Symptoms measured using the 9-item Patient Health Questionnaire. Scores range from 0 to 27. Higher scores indicate more severe depressive symptoms

    6 months and 12 months

  • Anxiety

    Symptoms measured using the 7-item Generalized Anxiety Disorder scale. Scores range from 0 to 21. Higher scores indicate more severe anxiety

    6 months and 12 months

  • Trauma symptoms for AYHIV <18 years

    Symptoms measured using the Child and Adolescent Trauma Screen. Scores range from 0 to 60. Higher scores indicate more severe trauma distress symptoms

    6 months and 12 months

  • Trauma symptoms for AYHIV ≥18 years

    Symptoms measured using the Post Traumatic Stress Disorder checklist for 5th edition of the Diagnostic and Statistical Manual of Mental Disorders. Scores range from 0 to 80. Higher scores indicate more severe trauma distress symptoms

    6 months and 12 months

Secondary Outcomes (1)

  • Viral suppression

    6 months and 12 months

Other Outcomes (2)

  • Reach

    Early implementation (3 months) and late implementation (12 months)

  • Implementation fidelity

    Early implementation (3 months) and late implementation (12 months)

Study Arms (2)

PROACT group

EXPERIMENTAL

Participants in intervention clinics with at least mild psychological distress (having depressive, anxiety or trauma symptoms) will receive a brief, modular, transdiagnostic psychological intervention (PROACT) delivered by non-specialist health providers at the HIV clinic.

Behavioral: Psychoeducation, Relaxation, PrOblem solving, Activation, Cognitive coping Therapy

Control group

ACTIVE COMPARATOR

Participants in control clinics with at least mild psychological distress (having depressive, anxiety or trauma symptoms) will be enrolled in the study, and will receive the standard of care interventions available in the HIV clinic.

Behavioral: Standard of care

Interventions

This is a brief transdiagnostic psychological intervention based on the trauma-focused cognitive behavioral therapy (TF-CBT) designed for delivery by non-specialist providers to adolescents and youth with psychological distress

Also known as: PROACT, Trauma-focused Cognitive Behavioral Therapy
PROACT group

Any intervention, including counseling, provided as a routine intervention at the HIV clinic selected as a control clinic

Control group

Eligibility Criteria

Age16 Years - 24 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Adolescent or youth ages 16-24 years attending HIV clinic at selected site with at least mild psychological distress who is willing to join the study and capable of providing consent to receive the intervention

You may not qualify if:

  • If any study procedure would put them at an increased risk or if their compliance with study procedures is not possible

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Nairobi

Nairobi, 00202, Kenya

Location

MeSH Terms

Conditions

DepressionAnxiety DisordersWounds and Injuries

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Central Study Contacts

Dalton Wamalwa, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Providers and participants will know the assigned arm
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Cluster randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 29, 2024

First Posted

February 8, 2024

Study Start

May 1, 2024

Primary Completion

December 1, 2025

Study Completion (Estimated)

May 1, 2028

Last Updated

February 8, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

We will share de-identified data collected from participants after publication upon request. Data will be provided in accordance with the applicable laws and regulations in the United States and Kenya, and following requirements as per the NOT-MH-14-015 on Data Sharing Expectations for NIMH-funded Clinical Trials. We will package our data in a user-friendly format to facilitate use by other investigators, with a codebook documenting all variable names and values. Common data elements will be used to the extent possible. Additionally, we will create a syntax file of all scoring algorithms for computed scales and strategies for identifying and managing missing data.

Shared Documents
STUDY PROTOCOL
Time Frame
The protocol will be available upon publication by June 2024 and the IPD will be available after publication of relevant papers
Access Criteria
Upon request to the study Principal Investigator

Locations